Clinical trial METASUN UCL-ONCO 2012-09
A proof of concept study to evaluate the use of metabonomics and lipidomics in predicting toxicity and efficacy of anti-VEGF therapy in patients with metastatic clear cell renal cell carcinoma
| Cancers | |
|---|---|
| Organ | Kidney |
| Trial status | Trial open for recruitment |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Academic trial | Oui |
| Sponsor | UCL St Luc |
| EudraCT Identifier | 2011-006085-40 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT02570789 |
| Inclusion criteria | Metastatic. RECIST v1.1 |
| Last update |